Baxter International Inc (BAX)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$25.83

Buy

$33.33

arrow-up$0.14 (+0.46%)

Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
Prices updated at 30 May 2025, 22:49 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.01%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. D. Brent Shafer
CEO
Mr. D. Brent Shafer
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
38,000
Head office
One Baxter Parkway
Deerfield
United States
60015
mobile
+1 224 948-2000
letter
Global_CORP_Investor_Relations@baxter.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Joel T. Grade
Executive Vice President and Chief Financial Officer
0.81m0.50m-6.51m-
Mr. D. Brent Shafer
Interim Chief Executive Officer and Chairman of the Board
0.17m--0.39m-
Ms. Anita A. Zielinski
Senior Vice President, Chief Accounting Officer and Controller
-----
Ms. Heather L. Knight
Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products and Therapies
0.88m--6.60m-
Ms. Jeanne K. Mason
Executive Vice President and Chief Human Resources Officer
-----
Ms. Patricia B. Morrison
Independent Director
0.13m--0.35m-
Dr. Stephen Newman Oesterle, M.D.
Independent Director
0.14m--0.37m-
Mr. Jeffrey A. Craig
Independent Director
0.04m--0.17m-
Ms. Amy A. Wendell
Independent Director
0.12m--0.35m-
Ms. Nancy M. Schlichting
Lead Independent Director
0.14m--0.37m-
Mr. Stephen H. Rusckowski
Independent Director
0.12m--0.35m-
Mr. James W. Borzi
Executive Vice President and Chief Supply Chain Officer
-----
Ms. Catherine R. Smith
Independent Director
0.15m--0.36m-
Mr. Alok Sonig
Executive Vice President and Group President, Pharmaceuticals
0.79m--5.35m-
Dr. David S. Wilkes, M.D.
Independent Director
0.12m--0.37m-
Mr. David S. Rosenbloom
Executive Vice President and General Counsel
-----
Mr. Reazur Rasul
Executive Vice President and Group President, Healthcare Systems and Technologies
-----
Mr. William A. Ampofo, II
Independent Director
0.11m--0.32m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc66,934,7410.0481233835495.32413130 Apr 202513.04
Vanguard Group Inc61,052,1070.037782951050.48571430 Apr 202511.90
Dodge & Cox51,458,9251.0039510816312.14706130 Apr 202510.03
Pzena Investment Management, LLC36,772,5664.3946731342709.31756530 Apr 20257.17
Dodge & Cox Stock Fund35,272,4001.065329632002.8074130 Apr 20256.87

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Mr. Christopher A. Toth29.16950,908183,876--
13 Dec 2024-Mr. Jose E. Almeida30.32180,889243,589--
02 Dec 2024-Mr. Joel T. Grade33.55221,83392,457--
02 Dec 2024-Ms. Heather L. Knight33.55202,676157,674--
02 Dec 2024-Mr. Reazur Rasul33.5568,174109,116--
09 Sep 2024-Mr. Jeffrey A. Craig--3,472--
03 Sep 2024-Mr. James W. Borzi37.8563,77766,853--
03 Sep 2024-Mr. Alok Sonig37.85115,594111,603--
03 Jun 2024-Mr. Christopher A. Toth34.08518,084213,282--
03 Jun 2024-Mr. David S. Rosenbloom34.0826,719108,580--
07 May 2024-Ms. Catherine R. Smith--22,545--
07 May 2024-Ms. Patricia B. Morrison--21,367--
07 May 2024-Mr. Peter M. Wilver--13,267--
07 May 2024-Dr. Stephen Newman Oesterle, M.D.--27,901--
07 May 2024-Ms. Amy A. Wendell--23,876--
07 May 2024-Ms. Nancy M. Schlichting--14,278--
07 May 2024-Mr. Stephen H. Rusckowski--9,068--
07 May 2024-Dr. David S. Wilkes--16,274--
07 May 2024-Mr. William A. Ampofo, II--9,847--
06 Mar 2024-Ms. Jeanne K. Mason--188,481--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.